BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31240592)

  • 21. Neutrophil to lymphocyte ratio as a prognostic marker for non-metastatic renal cell carcinoma - does it add to what we already know?
    Rawoot S; Punatar C; Singh V; Anand A; Shah B; Nagaonkar S; Joshi V
    Exp Oncol; 2021 Sep; 43(3):247-251. PubMed ID: 34591425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P53 and MDM2 Over-expression and Five-year Survival of Kidney Cancer Patients Undergoing Radical Nephrectomy--Iranian Experience.
    Abolhasani M; Salarinejad S; Asgari M
    Asian Pac J Cancer Prev; 2015; 16(12):5043-7. PubMed ID: 26163638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Significance of Pre- to Postoperative Dynamics of the Prognostic Nutritional Index for Patients with Renal Cell Carcinoma Who Underwent Radical Nephrectomy.
    Kang M; Chang CT; Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    Ann Surg Oncol; 2017 Dec; 24(13):4067-4075. PubMed ID: 28975525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The significant immunological characteristics of peripheral blood neutrophil-to-lymphocyte ratio and Fas ligand expression incidence in nephrectomized tumor in late recurrence from renal cell carcinoma.
    Sejima T; Iwamoto H; Morizane S; Hinata N; Yao A; Isoyama T; Saito M; Takenaka A
    Urol Oncol; 2013 Oct; 31(7):1343-9. PubMed ID: 22153754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
    Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
    BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic and predictive value of hematologic parameters in patients with metastatic renal cell carcinoma: second line sunitinib treatment following IFN-alpha.
    Dirican A; Kucukzeybek Y; Erten C; Somali I; Demir L; Can A; Payzin KB; Bayoglu IV; Akyol M; Yildiz Y; Koeseoglu M; Alacacioglu A; Tarhan MO
    Asian Pac J Cancer Prev; 2013; 14(3):2101-5. PubMed ID: 23679326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma.
    Ikuta S; Aihara T; Yamanaka N
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e109-e114. PubMed ID: 30632282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison and development of preoperative systemic inflammation markers-based models for the prediction of unfavorable pathology in newly diagnosed clinical T1 renal cell carcinoma.
    Liu H; Tang K; Chen Z; Li Z; Meng X; Xia D
    Pathol Res Pract; 2021 Sep; 225():153563. PubMed ID: 34371466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated neutrophil-lymphocyte ratio combined with hyponatremia indicate poor prognosis in renal cell carcinoma.
    Pedersen MM; Donskov F; Pedersen L; Zhang ZF; Nørgaard M
    Acta Oncol; 2020 Jan; 59(1):13-19. PubMed ID: 31448981
    [No Abstract]   [Full Text] [Related]  

  • 30. Preoperative Cholesterol Level Is Associated With Worse Pathological Outcomes and Postoperative Survival in Localized Renal Cell Carcinoma Patients: A Propensity Score-Matched Study.
    Lee H; Jeong CW; Kwak C; Kim HH; Seo SI; Lee HM; Oh JJ; Lee SC; Hong SK; Lee SE; Byun SS
    Clin Genitourin Cancer; 2017 Dec; 15(6):e935-e941. PubMed ID: 28558989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival in Renal Cell Carcinoma Patients Undergoing Nephrectomy.
    Jeon HG; Choi DK; Sung HH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    Ann Surg Oncol; 2016 Jan; 23(1):321-7. PubMed ID: 26045392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Significance of Preoperative Neutrophil - to - Lymphocyte Ratio in Renal Cell Carcinoma.
    Otunctemur A; Dursun M; Besiroglu H; Ozer K; Horsanali O; Ozbek E
    Int Braz J Urol; 2016; 42(4):678-84. PubMed ID: 27564277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
    Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K
    J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era.
    Sun F; Zhu J; Lu S; Zhen Z; Wang J; Huang J; Ding Z; Zeng M; Sun X
    BMC Cancer; 2018 Jan; 18(1):5. PubMed ID: 29291712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-treatment neutrophil-to-lymphocyte ratio predicts tumor pathology in newly diagnosed renal tumors.
    Viers BR; Thompson RH; Lohse CM; Cheville JC; Leibovich BC; Boorjian SA; Tollefson MK
    World J Urol; 2016 Dec; 34(12):1693-1699. PubMed ID: 27052014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutrophil-to-lymphocyte ratio as an independent predictor for survival in patients with localized clear cell renal cell carcinoma after radiofrequency ablation: a propensity score matching analysis.
    Chang X; Zhang F; Liu T; Wang W; Guo H
    Int Urol Nephrol; 2017 Jun; 49(6):967-974. PubMed ID: 28247169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
    Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of the dynamic changes of systemic inflammatory response in metastatic renal cell carcinoma.
    Wang B; Gu W; Wan F; Shi G; Ye D
    Int Braz J Urol; 2019; 45(1):89-99. PubMed ID: 29570259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.